CVS Health Corporation/ US1266501006 /
08/11/2024 22:10:00 | Chg. -1.53 | Volume | Bid02:00:00 | Ask02:00:00 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
55.54USD | -2.68% | 13.65 mill. Turnover: 592.84 mill. |
55.60Bid Size: 300 | 55.90Ask Size: 100 | 69.89 bill.USD | 4.36% | 8.56 |
Assets
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 10,292 | 11,349 | 12,044 | 12,606 | 12,896 | ||||||
Intangible Assets | 13,630 | 36,524 | 33,121 | 31,142 | 29,026 | ||||||
Long-Term Investments | - | 15,732 | 17,314 | 20,812 | 23,025 | ||||||
Fixed Assets | 63,902 | 151,213 | 172,147 | 174,346 | 172,991 | ||||||
Inventories | 15,296 | 16,450 | 17,516 | 18,496 | 17,760 | ||||||
Accounts Receivable | 13,181 | 17,631 | 19,617 | 21,742 | 24,431 | ||||||
Cash and Cash Equivalents | 1,696 | 4,059 | 5,683 | 7,854 | 9,408 | ||||||
Current Assets | 31,229 | 45,243 | 50,302 | 56,369 | 60,008 | ||||||
Total Assets | 95,131 | 196,456 | 222,449 | 230,715 | 232,999 |
Liabilities
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 8,863 | 8,925 | 10,492 | 11,138 | 12,544 | ||||||
Long-term debt | 22,181 | 71,444 | 64,699 | 59,207 | 51,971 | ||||||
Liabilities to Banks | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Provisions | 2,996 | 7,677 | 7,294 | 6,794 | 6,270 | ||||||
Liabilities | 57,436 | 137,913 | 158,279 | 161,014 | 157,618 | ||||||
Share Capital | - | - | - | - | - | ||||||
Total Equity | 37,695 | 58,543 | 64,170 | 69,701 | 75,381 | ||||||
Minority Interests | 4 | 318 | 306 | 312 | 306 | ||||||
Total liabilities equity | 95,131 | 196,456 | 222,449 | 230,715 | 232,999 |
Income Statement
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 184,765 | 194,579 | 256,776 | 268,706 | 292,111 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 9,517 | 4,021 | 11,987 | 13,911 | 13,193 | ||||||
Interest Income | 1,041 | 2,619 | 3,035 | 2,907 | 2,503 | ||||||
Income Before Taxes | 8,268 | 1,406 | 8,997 | 9,770 | 10,420 | ||||||
Income Taxes | 1,637 | 2,002 | 2,366 | 2,569 | 2,522 | ||||||
Minority Interests Profit | -1 | 2 | 3 | -13 | 12 | ||||||
Net Income | 6,622 | -594 | 6,634 | 7,179 | 7,910 |
Per Share
Cash Flow
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 8,007 | 8,865 | 12,848 | 15,865 | 18,265 | ||||||
Cash Flow from Investing Activities | -2,932 | -43,285 | -3,339 | -5,534 | -5,261 | ||||||
Cash Flow from Financing | -6,751 | 36,819 | -7,850 | -8,155 | -11,356 | ||||||
Decrease / Increase in Cash | -1,675 | 2,395 | 1,659 | 2,176 | 1,648 | ||||||
Employees | 246,000 | 295,000 | 290,000 | 300,000 | 300,000 |